Aurora Cannabis Inc (ACB)
$7.52 0.06 (0.80%)
8:08 EDT ACB Stock Quote Delayed 15 Minutes
Previous Close $7.46
Market Cap 0
PE Ratio -
Volume (Avg. Vol.) 28,146
Day's Range 7.42 - 7.66
52-Week Range 4.58 - 10.32
Dividend & Yield N/A (N/A)
ACB Stock Predictions, Articles, and Aurora Cannabis Inc News
- From InvestorPlace
- From the Web
Poor "paper" performances during earnings season have hurt cannabis investments like ACB stock, but the weed industry dances to a different beat.
Despite the downtrend since March, ACB stock has risen almost 45% in 2019. So let's take a look at what's going on with this leading cannabis producer
By David Moadel
While marijuana stocks have been under pressure, ACB stock looks like the cream of the crop. Keep an eye on Aurora's growth.
Options trading was buzzing in Canopy Growth, Microsoft and Netflix. Here are the metrics that matter moving forward.
Aurora has been languishing lately, even as other cannabis stocks have been rallying. But this could be an opportunity. The company does look poised for long-term trends, such as the CBD opportunity.
Aurora will lead the industry in some areas, but issues with ACB stock itself will make it difficult for investors to profit on Aurora stock.
CGC stock will report earnings on June 20th, just a day after it got the OK from shareholders for its $3.4 billion deal for Acreage Holdings.
ACB stock is still a very speculative name, but Aurora Cannabis' management has proven to be wise, and savvy.
I have concerns about Aurora Cannabis stock. For investors eager to cash-in on the pot stock craze, there are better choices than ACB stock.
Not all stocks under $20 are good stocks, but here are sub-$20 stocks to buy with a realistic opportunity to rally in a big way.
ACB stock is facing challenges which could continue to grow worse, but it would be a mistake to throw in the towel completely just yet.
Thursday’s 2.29% slide in CGC stock price reflects uncertainty about Canopy Growth’s forthcoming Q4 2019 results, cannabis market volatility.
A case can be made Aurora Cannabis stock has already experience a whopper of a retrenchment. ACB stock remains 38.12% below its 52-week high.
Long-term growth fundamentals provide support for ACB stock at $10, and near-term catalysts provide the firepower for a late 2019 rally.
The bears have all the reasons to clobber Aurora Canabis. Yet ACB stock is up 59% year to date and 400% overall. The bullish thesis persists.
Zynerba landed a new patent for its Zygel product to use cannabidiol as a treatment for Autism Spectrum Disorder, sending ZYNE stock ripping.
Aurora Cannabis has been stuck in a downtrend, but will ACB stock be able to breakout? Let's look at the charts to see what's going on.
Wednesday was very different for Cronos and Aurora, but if you own ACB stock, don't panic. There's still more room for growth.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!